{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:08:55Z","timestamp":1790172535039,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/brain\/awx192","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T11:09:56Z","timestamp":1499684996000},"page":"2295-2305","source":"Crossref","is-referenced-by-count":68,"title":["The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study"],"prefix":"10.1093","volume":"140","author":[{"given":"Grete","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Hedermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Witting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Duno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"key\n\t\t\t\t20171222065537_awx192-B1","article-title":"Aerobic training in myotonia congenita: effect on myotonia and fitness","year":"2016","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20171222065537_awx192-B2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.0000000000001808","article-title":"Aerobic training and postexercise protein in facioscapulohumeral muscular dystrophy: RCT study","volume":"85","year":"2015","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171222065537_awx192-B3","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1528-1157.1997.tb04522.x","article-title":"An overview of the efficacy and tolerability of new antiepileptic drugs","volume":"38","year":"1997","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20171222065537_awx192-B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.20295","article-title":"Phenotypic variability in myotonia congenita","volume":"32","year":"2005","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20171222065537_awx192-B5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2016.10.013","article-title":"Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity","volume":"113","year":"2017","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20171222065537_awx192-B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","year":"2008","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20171222065537_awx192-B7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nmd.2005.07.002","article-title":"Quantification of mobility impairment and self-assessment of stiffness in patients with myotonia congenita by the physiotherapist","volume":"15","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20171222065537_awx192-B8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mus.23683","article-title":"The diagnosis and treatment of myotonic disorders","volume":"47","year":"2013","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20171222065537_awx192-B9","first-page":"78","article-title":"Paramyotonia congenita (von Eulenburg) in Denmark","volume":"61","year":"1980","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20171222065537_awx192-B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1992.tb05103.x","article-title":"Treatment of myotonia with antiarrhythmic drugs","volume":"86","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20171222065537_awx192-B24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0b013e3181dc1a3a","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"74","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171222065537_awx192-B11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/awp294","article-title":"The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment","volume":"133","year":"2010","journal-title":"Brain J Neurol"},{"key":"key\n\t\t\t\t20171222065537_awx192-B12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","year":"1994","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20171222065537_awx192-B13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jphs.13116SC","article-title":"The effect of lamotrigine on Nav1.4 voltage-gated sodium channels","volume":"123","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"key\n\t\t\t\t20171222065537_awx192-B14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.32.8.827","article-title":"Electromyographic distinction between paramyotonia congenita and myotonia congenita: effect of cold","volume":"32","year":"1982","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171222065537_awx192-B15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.24331","article-title":"Sodium channel slow inactivation as a therapeutic target for myotonia congenita","volume":"77","year":"2015","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20171222065537_awx192-B16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00003088-199325060-00003","article-title":"Lamotrigine clinical pharmacokinetics","volume":"25","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20171222065537_awx192-B17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1468-1331.2012.03751.x","article-title":"Measuring quality of life impairment in skeletal muscle channelopathies","volume":"19","year":"2012","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20171222065537_awx192-B18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mus.25452","article-title":"The anti-convulsants lacosamide, lamotrigine and rufinamide reduce myotonia in isolated human and rat skeletal muscle","volume":"56","year":"2017","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20171222065537_awx192-B19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial","volume":"308","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171222065537_awx192-B20","first-page":"e803082","article-title":"The effects of the KCNQ openers retigabine and flupirtine on myotonia in mammalian skeletal muscle induced by a chloride channel blocker","volume":"2012","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"key\n\t\t\t\t20171222065537_awx192-B21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamaneurol.2015.2338","article-title":"Long-term safety and efficacy of mexiletine for patients with skeletal muscle channelopathies","volume":"72","year":"2015","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20171222065537_awx192-B22","article-title":"Drug treatment for myotonia [Internet]","volume-title":"Cochrane database of systematic reviews","year":"2006"},{"key":"key\n\t\t\t\t20171222065537_awx192-B23","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/brain\/awt133","article-title":"Non-dystrophic myotonia: prospective study of objective and patient reported outcomes","volume":"136","year":"2013","journal-title":"Brain"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/140\/9\/2295\/23030028\/awx192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T07:46:45Z","timestamp":1569743205000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/140\/9\/2295\/4096694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,8,24]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awx192","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,8,24]]}}}